Novel Nonsteroidal Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease in Type 2 Diabetes: A Step Change in Treatment?
Did you know that, beyond chronic kidney disease (CKD), patients with type 2 diabetes (T2D) are also at high risk for developing cardiovascular complications and even death?
Credit available for this activity expires: 1/24/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/986818?ecd=bdc_podcast_libsyn_mscpedu
Create your
podcast in
minutes
It is Free